News

Newsmogrifydigital2021-10-05T08:57:28+00:00

FEATURED

CONTENT

Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Dr. Louise Modis has been appointed to the Company’s executive leadership team as Chief Scientific Offier.

Louise is an accomplished scientific leader in therapeutic discovery and development, and holds considerable experience in the progression of pre-clinical and clinical-stage assets, across various modalities and therapeutic areas.

In her new role, Louise will lead the advancement of the Company’s internal programs to help address high unmet clinical need in ophthalmology, immuno-oncology and other disease areas.

Latest

NEWS

Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

Mark Cavanagh2021-01-12T18:56:58+00:009th October 2020|

Mogrify wins Life Science Innovation Award and Prof. Julian Gough named Academic Entrepreneur of the Year at Business Weekly Awards 2020

Mark Cavanagh2020-09-18T11:00:22+00:0018th September 2020|

Mogrify adds Dr. Lorenz Mayr to Board of Directors and Scientific Advisory Board

Betty Hou2020-08-11T14:01:48+00:0022nd July 2020|

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Mark Cavanagh2021-01-12T14:16:40+00:0021st April 2020|

Mogrify awarded $1.1M additional funding from SBRI Healthcare

Mark Cavanagh2021-01-11T10:40:49+00:0028th January 2020|

Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019

Mark Cavanagh2020-11-23T16:05:44+00:005th December 2019|

Load More Posts

Latest

Resources

VIEW ALL RESOURCES

VIEW ALL MEDIA FEATURES

VIEW ALL EVENTS

Follow Us On

Social Media